Paper33658587
Cell-free DNA concentration and fragment size as a biomarker for prostate cancer.
Chen E and 18 others. Sci Rep, 2021. Cited by 64 papers, by iCite.
Cite this record
ConductScience Library. Cell-free DNA concentration and fragment size as a biomarker for prostate cancer. Papers, record 33658587. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/33658587
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Publication types
- Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't
- PubMed
Topics18
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Biomarkers, Tumor | Major topic |
| Cell-Free Nucleic Acids | Major topic |
| Kallikreins | Major topic |
| Prostate-Specific Antigen | Major topic |
| Prostatectomy | Major topic |
| Prostatic Neoplasms | Major topic |
| Prostatic Neoplasms, Castration-Resistant | Major topic |
| Adult | |
| Aged | |
| Aged, 80 and over | |
| Area Under Curve | |
| Case-Control Studies | |
| Humans | |
| Logistic Models | |
| Male | |
| Middle Aged | |
| Prostate | |
| ROC Curve |
Source PubMed
Grants3
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| R01 CA088164 | NCI NIH HHS | United States | R01CA088164 | PubMed | NIH RePORTER |
| R01 CA088164 | NIH HHS | United States | R01CA088164 | PubMed | NIH RePORTER |
| R01 CA201358 | NCI NIH HHS | United States | R01CA201358 | PubMed and NIH | NIH RePORTER |
References31
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 30792266 | Guidelines for the Preanalytical Conditions for Analyzing Circulating Cell-Free DNA. | Clin Chem | 2019 | https://conductscience.org/library/papers/30792266 | PubMed |
| 2 | 24853859 | Towards standardisation of cell-free DNA measurement in plasma: controls for extraction efficiency, fragment size bias and quantification. | Anal Bioanal Chem | 2014 | https://conductscience.org/library/papers/24853859 | PubMed |
| 3 | 26493785 | Circulating free DNA concentration is an independent prognostic biomarker in lung cancer. | Eur Respir J | 2015 | https://conductscience.org/library/papers/26493785 | PubMed |
| 4 | 15036649 | Increased cell-free DNA in plasma of patients with metastatic spread in prostate cancer. | Cancer Lett | 2004 | https://conductscience.org/library/papers/15036649 | PubMed |
| 5 | 30400802 | Fragment size and level of cell-free DNA provide prognostic information in patients with advanced pancreatic cancer. | J Transl Med | 2018 | https://conductscience.org/library/papers/30400802 | PubMed |
| 6 | 12766024 | Changes in concentration of DNA in serum and plasma during storage of blood samples. | Clin Chem | 2003 | https://conductscience.org/library/papers/12766024 | PubMed |
| 7 | 11239235 | Quantitation of genomic DNA in plasma and serum samples: higher concentrations of genomic DNA found in serum than in plasma. | Transfusion | 2001 | https://conductscience.org/library/papers/11239235 | PubMed |
| 9 | 32122922 | Harmonizing Cell-Free DNA Collection and Processing Practices through Evidence-Based Guidance. | Clin Cancer Res | 2020 | https://conductscience.org/library/papers/32122922 | PubMed |
| 10 | 23779229 | Plasma cell-free DNA and its DNA integrity as biomarker to distinguish prostate cancer from benign prostatic hyperplasia in patients with increased serum prostate-specific antigen. | Int Urol Nephrol | 2013 | https://conductscience.org/library/papers/23779229 | PubMed |
| 11 | 11694251 | About the possible origin and mechanism of circulating DNA apoptosis and active DNA release. | Clin Chim Acta | 2001 | https://conductscience.org/library/papers/11694251 | PubMed |
| 12 | 18337732 | Prostate-specific antigen and prostate cancer: prediction, detection and monitoring. | Nat Rev Cancer | 2008 | https://conductscience.org/library/papers/18337732 | PubMed |
| 13 | 4959277 | Deoxybonucleic acid (DNA) and antibodies to DNA in the serum of patients with systemic lupus erythematosus. | J Clin Invest | 1966 | https://conductscience.org/library/papers/4959277 | PubMed |
| 14 | 30181813 | Prognostic significance of six clinicopathological features for biochemical recurrence after radical prostatectomy: a systematic review and meta-analysis. | Oncotarget | 2018 | https://conductscience.org/library/papers/30181813 | PubMed |
| 15 | 19762255 | The role of cell-free circulating DNA in the diagnosis and prognosis of prostate cancer. | Urol Oncol | 2011 | https://conductscience.org/library/papers/19762255 | PubMed |
| 16 | 4629907 | The occurrence of single-stranded DNA in the serum of patients with systemic lupus erythematosus and other diseases. | J Clin Invest | 1973 | https://conductscience.org/library/papers/4629907 | PubMed |
| 17 | 11861434 | Predominant hematopoietic origin of cell-free DNA in plasma and serum after sex-mismatched bone marrow transplantation. | Clin Chem | 2002 | https://conductscience.org/library/papers/11861434 | PubMed |
| 18 | 25646427 | Lengthening and shortening of plasma DNA in hepatocellular carcinoma patients. | Proc Natl Acad Sci U S A | 2015 | https://conductscience.org/library/papers/25646427 | PubMed |
| 19 | 24998118 | Combined value of validated clinical and genomic risk stratification tools for predicting prostate cancer mortality in a high-risk prostatectomy cohort. | Eur Urol | 2015 | https://conductscience.org/library/papers/24998118 | PubMed |
| 20 | 17875764 | Prognostic value of preoperative serum cell-free circulating DNA in men with prostate cancer undergoing radical prostatectomy. | Clin Cancer Res | 2007 | https://conductscience.org/library/papers/17875764 | PubMed |
| 21 | 27428049 | Fragment Length of Circulating Tumor DNA. | PLoS Genet | 2016 | https://conductscience.org/library/papers/27428049 | PubMed |
Cited by51
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 64 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42769660 | Relevance of existing blood-based biomarkers for detection of hepatocellular carcinoma: a prospective case-control study. | J Circ Biomark | 2026 | https://conductscience.org/library/papers/42769660 | PubMed |
| 42396659 | Evolving role of biomarkers beyond prostate‑specific antigen in refining prostate cancer screening: From blood‑based tests to urinary and genetic markers (Review). | Mol Med Rep | 2026 | https://conductscience.org/library/papers/42396659 | PubMed |
| 42122162 | Liquid Biopsy in Advanced Prostate Cancer. | Cancers (Basel) | 2026 | https://conductscience.org/library/papers/42122162 | PubMed |
| 42072359 | Integrative Whole-Genome and Epigenome Profiling of cfDNA in Familial Prostate Cancer: Insights from a Pilot Study. | Biomedicines | 2026 | https://conductscience.org/library/papers/42072359 | PubMed |
| 41897554 | Systematic Review of Methods for Measuring Circulating Cell-Free DNA in Plasma of Healthy Individuals. | Diagnostics (Basel) | 2026 | https://conductscience.org/library/papers/41897554 | PubMed |
| 41211651 | Diagnostic and Prognostic Value of cfDNA Concentration and Fragmentation in Prostate Cancer. | Prostate | 2026 | https://conductscience.org/library/papers/41211651 | PubMed |
| 40863429 | The Evolving Landscape of Novel and Old Biomarkers in Localized High-Risk Prostate Cancer: State of the Art, Clinical Utility, and Limitations Toward Precision Oncology. | J Pers Med | 2025 | https://conductscience.org/library/papers/40863429 | PubMed |
| 40805284 | Circulating Tumor DNA in Prostate Cancer: A Dual Perspective on Early Detection and Advanced Disease Management. | Cancers (Basel) | 2025 | https://conductscience.org/library/papers/40805284 | PubMed |
| 40565311 | Refined Procedure to Purify and Sequence Circulating Cell-Free DNA in Prostate Cancer. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/40565311 | PubMed |
| 39984815 | Application of Z-scan technique in detecting circulating free DNA for prostate cancer diagnosis and monitoring. | Lasers Med Sci | 2025 | https://conductscience.org/library/papers/39984815 | PubMed |
| 39901737 | Stoichiometric constraints for detection of EV-borne biomarkers in blood. | J Extracell Vesicles | 2025 | https://conductscience.org/library/papers/39901737 | PubMed |
| 39872607 | Early detection of canine hemangiosarcoma via cfDNA fragmentation and copy number alterations in liquid biopsies using machine learning. | Front Vet Sci | 2024 | https://conductscience.org/library/papers/39872607 | PubMed |
| 39805703 | Nanopore-based consensus sequencing enables accurate multimodal tumor cell-free DNA profiling. | Genome Res | 2025 | https://conductscience.org/library/papers/39805703 | PubMed |
| 39697489 | Expanded knowledge of cell-free DNA biology: potential to broaden the clinical utility. | Extracell Vesicles Circ Nucl Acids | 2022 | https://conductscience.org/library/papers/39697489 | PubMed |
| 39694939 | cfDNA fragmentation patterns correlate with tumor burden measured via PSMA PET/CT volumetric parameters in patients with biochemical recurrence of prostate cancer. | EJNMMI Res | 2024 | https://conductscience.org/library/papers/39694939 | PubMed |
| 39518429 | Ultrashort Cell-Free DNA Fragments and Vimentin-Positive Circulating Tumor Cells for Predicting Early Recurrence in Patients with Biliary Tract Cancer. | Diagnostics (Basel) | 2024 | https://conductscience.org/library/papers/39518429 | PubMed |
| 39451616 | Role of Liquid Biopsy in Progressive PSA Patients after Radical Prostatectomy. | Diagnostics (Basel) | 2024 | https://conductscience.org/library/papers/39451616 | PubMed |
| 39208374 | A Targeted Methylation-Based Multicancer Early Detection Blood Test Preferentially Detects High-Grade Prostate Cancer While Minimizing Overdiagnosis of Indolent Disease. | JCO Precis Oncol | 2024 | https://conductscience.org/library/papers/39208374 | PubMed |
| 39000483 | Detection and Characterization of Methylated Circulating Tumor DNA in Gastric Cancer. | Int J Mol Sci | 2024 | https://conductscience.org/library/papers/39000483 | PubMed |
| 38938580 | Circulating extracellular vesicles provide valuable protein, but not DNA, biomarkers in metastatic breast cancer. | J Extracell Biol | 2022 | https://conductscience.org/library/papers/38938580 | PubMed |
Genes7
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| APC | 324 | PubTator's text mining | https://conductscience.org/library/genes/324 | NCBI Gene |
| GPI | 2821 | PubTator's text mining | https://conductscience.org/library/genes/2821 | NCBI Gene |
| GSTP1 | 2950 | PubTator's text mining | https://conductscience.org/library/genes/2950 | NCBI Gene |
| KLK3 | 354 | PubTator's text mining | https://conductscience.org/library/genes/354 | NCBI Gene |
| NPEPPS | 9520 | PubTator's text mining | https://conductscience.org/library/genes/9520 | NCBI Gene |
| PCA3 | 50652 | PubTator's text mining | https://conductscience.org/library/genes/50652 | NCBI Gene |
| RASSF1 | 11186 | PubTator's text mining | https://conductscience.org/library/genes/11186 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/33658587
GET https://conductscience.org/api/papers/v1/33658587/references?page=2